Nathaniel G.N. Milton

1.4k total citations
42 papers, 1.2k citations indexed

About

Nathaniel G.N. Milton is a scholar working on Molecular Biology, Physiology and Behavioral Neuroscience. According to data from OpenAlex, Nathaniel G.N. Milton has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Physiology and 9 papers in Behavioral Neuroscience. Recurrent topics in Nathaniel G.N. Milton's work include Alzheimer's disease research and treatments (17 papers), Stress Responses and Cortisol (9 papers) and Prion Diseases and Protein Misfolding (6 papers). Nathaniel G.N. Milton is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Stress Responses and Cortisol (9 papers) and Prion Diseases and Protein Misfolding (6 papers). Nathaniel G.N. Milton collaborates with scholars based in United Kingdom, Germany and France. Nathaniel G.N. Milton's co-authors include Edward W. Hillhouse, E. W. Hillhouse, J. Robin Harris, Dimitris Grammatopoulos, H.W.P. Quartero, Patsy Coskeran, Janet Treasure, A. S. Milton, David S. Latchman and Jean‐Pierre Changeux and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nathaniel G.N. Milton

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nathaniel G.N. Milton

Since Specialization

Citations

This map shows the geographic impact of Nathaniel G.N. Milton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel G.N. Milton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel G.N. Milton more than expected).

Fields of papers citing papers by Nathaniel G.N. Milton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel G.N. Milton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel G.N. Milton. The network helps show where Nathaniel G.N. Milton may publish in the future.

Co-authorship network of co-authors of Nathaniel G.N. Milton

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel G.N. Milton. A scholar is included among the top collaborators of Nathaniel G.N. Milton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel G.N. Milton. Nathaniel G.N. Milton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making? 2023 ·PubMed ·Nathaniel G.N. Milton	4
2	The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction 2020 ·Neural Regeneration Research ·Andrew Paterson, (unknown), Margarita Gomez Escalada, Nathaniel G.N. Milton	17
3	Immunocytochemical staining of endogenous nuclear proteins with the HIS-1 anti-poly-histidine monoclonal antibody: A potential source of error in His-tagged protein detection 2014 ·Acta Histochemica ·(unknown), Anatoliy Markiv, Nathaniel G.N. Milton	5
4	Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide 2012 ·Micron ·Nathaniel G.N. Milton, J. Robin Harris	23
5	Cholesterol in Alzheimer’s Disease and other Amyloidogenic Disorders 2010 ·Sub-cellular biochemistry ·J. Robin Harris, Nathaniel G.N. Milton	36
6	Polymorphism of amyloid-β fibrils and its effects on human erythrocyte catalase binding 2009 ·Micron ·Nathaniel G.N. Milton, J. Robin Harris	21
7	Phosphorylated Amyloid-β: the Toxic Intermediate in Alzheimer’s Disease Neurodegeneration 2006 ·PubMed ·Nathaniel G.N. Milton	19
8	Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease 2004 ·Drugs & Aging ·Nathaniel G.N. Milton	119
9	Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide 2002 ·Neuroscience Letters ·Nathaniel G.N. Milton	100
10	The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity 2002 ·Neuroscience Letters ·Nathaniel G.N. Milton	11
11	Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk 2002 ·Journal of Clinical Pathology ·(unknown), I.A. Jagroop, Hugh Montgomery, Michael A. Thomas, Dimitri P. Mikhailidis, Nathaniel G.N. Milton, A F Winder	23
12	Inhibition of Catalase Activity with 3-Amino-Triazole Enhances the Cytotoxicity of the Alzheimer’s Amyloid-β Peptide 2001 ·NeuroToxicology ·Nathaniel G.N. Milton	55
13	Identification of amyloid-β binding sites using an antisense peptide approach 2001 ·Neuroreport ·Nathaniel G.N. Milton, Neema P. Mayor, John L. Rawlinson	27
14	The Neuronal Nicotinic Acetylcholine Receptor α2 Subunit Gene Promoter Is Activated by the Brn-3b POU Family Transcription Factor and Not by Brn-3a or Brn-3c 1995 ·Journal of Biological Chemistry ·Nathaniel G.N. Milton, Alain Bessis, Jean‐Pierre Changeux, David S. Latchman	28
15	The human myometrial CRH receptor: G proteins and second messengers 1994 ·Molecular and Cellular Endocrinology ·Dimitris Grammatopoulos, Nathaniel G.N. Milton, Edward W. Hillhouse	40
16	Modulation of the prostaglandin responses of conscious rabbits to the pyrogen polyinosinic: polycytidylic acid by corticotrophin-releasing factor-41 1993 ·Journal of Endocrinology ·Nathaniel G.N. Milton, Edward W. Hillhouse, A. S. Milton	3
17	Activation of the hypothalamo-pituitary-adrenocortical axis in the conscious rabbit by the pyrogen polyinosinic: polycytidylic acid is dependent on corticotrophin-releasing factor-41 1992 ·Journal of Endocrinology ·Nathaniel G.N. Milton, E. W. Hillhouse, A. S. Milton	19
18	Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41 1990 ·Journal of Molecular Endocrinology ·Nathaniel G.N. Milton, E. W. Hillhouse, (unknown), Colin H. Self, Anthony McGregor	6
19	Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro 1989 ·Journal of Endocrinology ·Edward W. Hillhouse, Nathaniel G.N. Milton	44
20	Effect of noradrenaline and γ-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro 1989 ·Journal of Endocrinology ·Edward W. Hillhouse, Nathaniel G.N. Milton	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact